Our Impact

“We are very proud of the folks who are working on building our program, and the people from around Michigan and beyond who have believed in and supported the Chad Carr Pediatric Brain Tumor Center. The sky is the limit for where we can take this center from here.”

CC-PBTC pilot grants of $4.3 million (2017–2022) led to raising more than $22 million in grant funding (more than a five-fold impact) n

2020 and 2021 funding is combined due to COVID-19 pandemic.

Pushing For Breakthroughs

Since 2018, the CC-PBTC has become a highly collaborative environment, already resulting in translational discoveries that are affecting our understanding and treatment of high-risk pediatric brain tumors.

n 73.45% NIH/DOD n

More than 70% of grant funding is from government National Institutes of Health (NIH) and Department of Defense (DOD) support $5.8M $16.2M

TOTAL = $22M

The center is inspiring breakthroughs by spurring institutional, national, and international collaborations and through innovative research, promising clinical trials and the support of unique approaches.

CC-PBTC RESEARCHERS

>125 papers published focused on several pediatric brain tumors including DIPG, pediatric high-grade glioma, ependymoma, medulloblastoma and atypical teratoid/rhabdoid tumor (AT/RT).

michmed.org/CCPBTCpubs